Navigation Links
CardioVascularCS.Org, a division of EndoVascular Forum, Inc., Partners with Complex Interventional Cardiovascular Therapy (CICT) to Extend Electronic Medical Care Advancement
Date:6/2/2009

CardioVascularCS.Org and CICT collaborate by reconstructing cardiovascular clinical experiences presented virtually at the annual CICT conference

BOSTON, June 2 /PRNewswire/ -- The EndoVascular Forum, Inc. (EVF), an IC Sciences Company, and its partner Complex Interventional Cardiovascular Therapy (CICT) announced a collaboration using EVF's CardioVascularCS.Org operating division to extend the influence of Electronic Medical Care Advancement for complex clinical skills development in Cardiovascular medicine. The partnership underscores the EndoVascular Forum's commitment to developing a new generation of tools for physicians to learn from peer experiences and to improve clinical treatment decisions and practices. "We are pleased to have the opportunity to collaborate with Complex Interventional Cardiovascular Therapy," said John Heinen, Chief Technology Officer of Informed Clinical Sciences Corporation. "It is the mutual goal of CardioVascularSC.Org and the CICT that this will lead to a stronger partnership in the exchange of clinical experience through case studies and experiential narratives, as well as traffic general observations, clinical pearls, tips, and best practices regarding diagnostic skills, procedural skills, clinical data, and discoveries."

It is now commonly accepted that the Internet is powering a new era of Electronic Medical Care, science, and clinical development in which the massive integration of experiences and observations in and of themselves form a complementary, accelerated path to knowledge generation and dissemination. "The end goal of this partnership is to expand and to extend the essential link that exists between physicians learning from one another at the annual CICT meeting to the CardioVascularCS.Org platform in a way that provides the tools and support on an optimized virtual platform that allows for medical specialists to effectively treat their patients, seek to improve outcomes, and collaborate to advance health care," said Issam D. Moussa, MD and co-director of CICT. The Cardiovascular Forum's online, global clinician network of 11,000 physicians provides an experientially diverse community ideal for collective intelligence engagement around cardiovascular medicine and care.

The CardioVascular Forum's Electronic Medical Care Advancement instruments are part of the class of collective intelligence instruments that apply scientific design principles to effectively engage groups of clinicians or patients in exchanging information, observations, and viewpoints to advance the community's collective intelligence. Techniques employed for high-impact collective intelligence instruments include narrative tools, user-generated tagging, and meta-data collection.

About Complex Interventional Cardiovascular Therapy

The Mission of CICT is to promote high-quality, patient centered, clinical and technical decision-making in the field of Interventional Cardiovascular Medicine. CICT will accomplish its mission by creating a Forum where experts in cardiac and vascular interventions share their experiences with an audience of their peers through interactive complex case presentations. This forum will encourage open and critical discussion of the material presented, as well as relevant "standards of care." The overriding goal of this meeting is to emphasize the role of critical thinking and clinical judgment in transferring knowledge from the evidence based medicine repertoire to the bedside. To learn more about CICT, please visit cict2009.org.

About EndoVascular Forum, Inc.

Founded in 1996, the EndoVascular Forum, Inc. is one of the world's longest standing specialty specific medical forums dedicated to cardiovascular and endovascular specialists. The EVF is an international case study and discussion forum developed and hosted by IC Sciences Corporation (www.ICSciences.com). The EVF NGHI (next generation health Internet) community comes together to share clinical observations, findings, and cases that all serve to accelerate the awareness and adoption of the most innovative and sometimes controversial procedures among physicians in the minimally invasive medical community. To learn more about the EndoVascular Forum, please visit www.Endovascular.org.

About Informed Clinical Sciences Corporation

IC Sciences Corporation is a closely held, private organization pioneering in the medical information sciences and informed clinical technology electronic markets. The company's core business involves designing, developing, delivering, and advancing a series of informatics instrument classes, including care delivery, cognitive profiling, collective intelligence, therapeutic support, and performance evaluation. For more information, please visit www.ICSciences.com.

    Contact:
    IC Sciences Corporation
    publicrelations@icsciences.com
    One Joy Street
    Boston, MA 02108
    1-866-804-6296


'/>"/>
SOURCE IC Sciences Corporation
Copyright©2009 PR Newswire.
All rights reserved

Related medicine technology :

1. Strykers Biotech Division Receives FDA Warning Letter
2. Trellis(R) Peripheral Infusion System Removes Blood Clots in Largest Reported Prospective Endovascular DVT (Deep Vein Thrombosis) Patient Series
3. Hydrox Inc., Cardinal Health Issue Nationwide Recall of Alcohol-Free Mouthwash For Hospitals
4. CMS, Inc., an Elekta Company, Announces First Cancer Patients Treated With Monaco(TM) Radiation Treatment Planning System
5. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
6. Multiple Myeloma Research Consortium (MMRC) Partners with Novartis to Advance Phase II Study of Deacetylase Inhibitor
7. Harvard Medical School-Partners HealthCare Center for Genetics and Genomics Successfully Completes Evaluation of AutoGenomics 2C9-VKORC1 Panel to Assess Warfarin Sensitivity
8. HistoRx and Radiation Therapy Oncology Group Initiate Brain Tumor Biomarker Research Partnership
9. The Leukemia & Lymphoma Society and Cleveland Clinic Taussig Cancer Institute Announce Groundbreaking Partnership to Accelerate Drug Approvals
10. PDHI Launches ConXus Rewards, Announces Partnership With Hallmark Insights to Support Incentive-Driven Wellness Programs
11. UNICEF Partners With Causes on Facebook to Launch Charity Gift Feature
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:9/12/2017)... 12, 2017  ValGenesis Inc., the global leader ... pleased to announce the appointment of Dr. ... Board of Directors and Chairman of Advisory Board ... science companies to manage their entire validation lifecycle ... in this process. Furthermore, ValGenesis VLMS enables rigorous ...
(Date:9/9/2017)... Sept. 9, 2017  Eli Lilly and Company (NYSE: ... secondary endpoint data for lasmiditan, an investigational, oral, first-in-class ... statistically significant improvements compared to placebo in the Phase ... at the 18th Congress of the International Headache Society ... "The data presented today demonstrate lasmiditan,s potential to reduce ...
(Date:9/7/2017)... 7, 2017 Caris Life Sciences, a ... the promise of precision medicine, today announced results ... of its molecular profiling approach in guiding therapeutic ... profiling plus (CGP+) with Caris Molecular Intelligence ® ... a molecular level, leading to more therapeutic options ...
Breaking Medicine Technology:
(Date:9/20/2017)... (PRWEB) , ... September 20, 2017 , ... “Finn Mouseson”: ... take precedence in an average life. This mouse sets out on a journey that ... heart. “Finn Mouseson” is the creation of newly published author and illustrator, Melody Gersonde-Mickelson, ...
(Date:9/20/2017)... ... ... “The Financial Favor of God; Second Edition”: a personal and exquisite recipe ... creation of published author, Brooks Rathell. , “We typically hear about the favor of ... financial favor of God. Not only does it exist, but it is meant for ...
(Date:9/19/2017)... ... September 19, 2017 , ... DeSola Group, ... marketing leader, Denise Flannery, to its strategic advisory and client development team. ... will work with clients across different industries to develop and implement market-justified strategies, ...
(Date:9/19/2017)... ... 2017 , ... The Lymphoma Research Foundation (LRF) – the ... the lymphoma community through a comprehensive series of education programs, outreach initiatives and ... Swirl: A Wine Tasting Event series on Thursday, October 26, 2017. Hosted at ...
(Date:9/19/2017)... MD (PRWEB) , ... September 19, 2017 , ... ... the Society of Professional Benefit Administrators (SPBA) hosted “Expanding Your Success” ... for SPBA Members as it focused on best practices for third party administrators ...
Breaking Medicine News(10 mins):